How well do diagnosis-related group systems group breast cancer surgery patients?-evidence from 10 European countries

Health Economics (United Kingdom)

Volumn 21, Issue SUPPL. 2, 2012, Pages 41-54

  Scheller Kreinsen, David ^a  

^a TECHNISCHE UNIVERSITÄT BERLIN   (Germany)

Author keywords

breast cancer; diagnosis related groups; DRGs; Europe; hospital financing; payment

Indexed keywords

ALGORITHM; ARTICLE; BREAST CANCER; BREAST RECONSTRUCTION; CANCER PATIENT; CANCER SURGERY; DIAGNOSIS RELATED GROUP; DISEASE SEVERITY; EUROPEAN UNION; HEALTH CARE COST; HEALTH CARE POLICY; HOSPITAL COST; HUMAN; LENGTH OF STAY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MASTECTOMY; PATIENT SAFETY; PRIORITY JOURNAL; SURGICAL INFECTION; URINARY TRACT INFECTION;

AGE FACTORS; BREAST NEOPLASMS; DIAGNOSIS-RELATED GROUPS; EUROPE; FEMALE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MASTECTOMY; MODELS, ECONOMIC; POSTOPERATIVE COMPLICATIONS;

EID: 84864136496     PISSN: 10579230     EISSN: 10991050     Source Type: Journal    
DOI: 10.1002/hec.2832     Document Type: Article

References (33)

1. Barlow WE, Taplin SH, Yoshida CK, Buist DS, Seger D, Brown M,. 2001. Cost Comparison of Mastectomy Versus Breast-Conserving Therapy for Early-Stage Breast Cancer. Journal of the National Cancer Institute 93 (6): 447-455.
2. Berki SE,. 1985. DRGs, incentives, hospitals, and physicians. Health Affairs 4: 70-76.
3. Burau V, Blank RH,. 2006. Comparing Health Policy: An Assessment of Typologies of Health Systems. Journal of Comparative Policy Analysis 8 (1): 63-76.
4. Busse R, Geissler A, Quentin W, Wiley M, (eds). 2011. Diagnosis-Related Groups in Europe: Moving towards transparency, efficiency and quality in hospitals. Open University Press: Maidenhead.
5. Busse R, Quentin W,. 2011. Moving towards transparency, efficiency and quality in hospitals: conclusions and recommendations. In Diagnosis-Related Groups in Europe: Moving towards transparency, efficiency and quality in hospitals, Busse R, Geissler A, Quentin W, Wiley M, (eds.). Open University Press: Maidenhead.
6. Bradley CJ, Given C, Baser O, Gardiner J,. 2003. Influence of surgical and treatment choices on the cost of breast cancer care. The European Journal of Health Economics 4: 96-101.
7. Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Jahanzeb M, Kiel K, Ljung BM, Marcom PK, Mayer IA, McCormick B, Nabell LM, Pierce LJ, Reed EC, Smith ML, Somlo G, Theriault RL, Topham NS, Ward JH, Winer EP, Wolff AC, NCCN Breast Cancer Clinical Practice Guidelines Panel. 2009. Breast cancer. Clinical practice guidelines in oncolog. Journal of the National Comprehensive Cancer Network 7 (2): 122-192.
8. Cots F, Chiarello P, Salvador X, Castells X, Quentin W,. 2011. DRG-based hospital payment: Intended and unintended consequences. In Diagnosis-Related Groups in Europe: Moving towards transparency, efficiency and quality in hospitals, Busse R, Geissler A, Quentin W, Wiley M, (eds.). Open University Press: Maidenhead.
9. Downing A, Lansdow M, West RM, Thomas JD, Lawrence G, Forman D,. 2009. Changes in and predictors of length of stay in hospital after surgery for breast cancer between 1997/98 and 2004/05 in two regions of England: a population-based study. BMC Health Services Research 9: 202.
10. Ellis RP,. 1998. Creaming, skimping and dumping: provider competition on the intensive and extensive margins. Journal of Health Economics 17: 537-555.
11. Foster TS, Miller JD, Boye ME, Blieden MB, Gidwani R, Russel MW,. 2011. The economic burden of metastatic breast cancer: A systematic review of literature from developed countries. Cancer Treatment Reviews 37 (6): 405-415.
12. Geissler A, Quentin W, Scheller-Kreinsen D, Busse R,. 2011. Introduction to DRGs in Europe: Common objectives across different hospital systems. In Diagnosis-Related Groups in Europe: Moving towards transparency, efficiency and quality in hospitals, Busse R, Geissler A, Quentin W, Wiley M, (eds.). Open University Press: Maidenhead.
13. Hafsteinsdottir EJG, Siciliani L,. 2009. DRG prospective payment systems: refine or not refine? Health Economics 19 (10): 1226-1239.
14. Hospital Data Project. 2008. Hospital Data Project Phase 2-Final Report-The equal need for metadata and data. Extension on DIAGNOSIS and Shortlist PROCEDURES. [01.10.2011]
15. Hvenegaard A, Street A, Sorensen TH, Gyrd-Hansen D,. 2009. Comparing hospital costs: What is gained by accounting for more than a case-mix index? Social Science & Medicine 69: 640-647.
16. Jacobs VR, Rasche L, Harbeck N, Warm M, Mallmann P,. 2010. Underfinancing of 90.3% for Implant Costs of Prostheses and Expanders in DRG Revenues for Uni- and Bilateral Mastectomy with Immediate Breast Reconstruction. Onkologie 33: 584-588.
17. Kaufmann M, Morrow M, von Minckwitz G, Harris JR, Biedenkopf Expert Panel Members. 2010. Locoregional treatment of primary breast cancer: consensus recommendations from an International Expert Panel. Cancer 116 (5): 1184-1191.
18. Kobel C, Thuilliez J, Bellander M, Pfeiffer KP,. 2011. DRG systems and similar patient classification systems in Europe. In Diagnosis-Related Groups in Europe: Moving towards transparency, efficiency and quality in hospitals, Busse R, Geissler A, Quentin W, Wiley M, (eds.). Open University Press: Maidenhead.
19. Kuwabara H, Fushimi K,. 2009. The impact of a new payment system with case-mix measurement on hospital practices for breast cancer patients in Japan. Health Policy 92: 65-72.
20. Laudicella M, Olsen KR, Street A,. 2010. Examining cost variation across hospital departments-a two stage multilevel approach using patient level data. Social Science & Medicine 71: 1871-1881.
21. Lave JR,. 1989. The effect of Medicare prospective payment system. Annual Reviews of Public Health 10: 141-161.
22. Levaggi R, Montefiori M,. 2003. Horizontal and Vertical Cream-Skimming in the Health Care Market. DISEFIN Working Paper, 11/2003, Rochester, NY: Social Science Research Network.[5th January 2012]
23. Lidgren M, Wilkin N, Bengt J,. 2007. Cost of breast cancer in Sweden in 2002. The European Journal of Health Economics 8: 5-15.
24. Martinussen PE, Hagen TP,. 2009. Reimbursement systems, organizational forms and patient selection: evidence from day surgery in Norway. Health Economics, Policy, and Law 4: 139-158.
25. Miraldo M, Goddard M, Smith P,. 2006. The Incentive Effects of Payment by Results. York: University of York Centre for Health Economics, CHE Research Paper 19.
26. Newhouse JP, Byrne DJ,. 1988. Did Medicare's prospective payment system cause length of stay to fall? Journal of Health Economics 7: 413-416.
27. Organisation for Economic Co-operation and Development (OECD) Health Data. n.d. Age-standardised death rate per 100 000 population for breast cancer. [1 September 2011].
28. Peltoniemi P, Peltola M, Hakulinen T, Häkkinen U, Pylkkänen L, Kolli H,. 2011. The Effect of Hospital Volume on the Outcome of Breast Cancer Surgery. Annals of Surgical Oncology 18: 1684-1690.
29. Scheller-Kreinsen D, Quentin W, Busse R,. 2011. DRG-based hospital payment systems and technological innovations in 12 European countries. Value in Health 14 (8): 1166-1172.
30. Street A, Kobel C, Renaud T, Thuilliez J, EuroDRG group. 2012. How well do Diagnosis Related Groups explain variations in costs or length of stay among patients and across hospitals? Methods for analysing routine patient data. Health Economics 21 (Suppl 2): 6-18.
31. Tan SS, Serden L, Geissler A, van Ineveld M, Redekop K, Heurgren M, Hakkard-van Roijen, 2011. DRGs and cost accounting: Which is driving which? In Diagnosis-Related Groups in Europe: Moving towards transparency, efficiency and quality in hospitals, Busse R, Geissler A, Quentin W, Wiley M, (eds.). Open University Press: Maidenhead.
32. Wendt C, Frisina L, Rothgang H,. 2009. Healthcare System Types: A Conceptual Framework for Comparison. Social Policy & Administration 43 (1): 70-90.
33. World Health Organization (WHO). 2011. Cancer Fact sheet No. 297. World Health Organization: Geneva.